Digestive Endoscopy Suite Radiation Controlling Protective Strategies
NCT02063841 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2015-08-20
Summary
ERCP is associated with radiation exposure to the endoscopist and staff, which may be significant at high volume programs despite the use of lead aprons. We hypothesize that draping of the fluoroscopy image intensifier may significantly reduce staff radiation exposure and help achieve implementation of the ALARA (As Low As Reasonably Achievable) principle.
Conditions
- Radiation Exposure
Interventions
- DEVICE
-
lead-free protective drape containing bismuth and antimony (RADPAD®)
- DEVICE
-
sterile identical sham drape
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
Priya Jamidar, MD · Yale University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 45 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
Countries
- United States
More Related Trials
-
Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)
NCT02598128 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
NCT01456468 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
NCT03345589 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
NCT01846806 ·Status: TERMINATED ·Phase: NA
-
Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube
NCT00999232 ·Status: COMPLETED ·Phase: PHASE4
-
AST-120 Used to Treat Mild Hepatic Encephalopathy
NCT00867698 ·Status: COMPLETED ·Phase: PHASE2
-
Alpha-1 Antitrypsin (AAT) Enhances Islet Autograft Survival in Patients With Chronic Pancreatitis
NCT02947087 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
NCT06843148 ·Status: RECRUITING ·Phase: NA
-
Trial to Evaluate the Efficacy of a Manualized Reflective Writing Program for Clinical Phase Physician Assistant (PA) Students.
NCT06000488 ·Status: WITHDRAWN ·Phase: NA
-
Lipid Emulsions and Liver Function - Results After 5 Years.
NCT04347902 ·Status: COMPLETED ·Phase: PHASE4
-
Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans
NCT03201952 ·Status: TERMINATED ·Phase: PHASE1
-
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
NCT03359174 ·Status: TERMINATED ·Phase: PHASE2
-
Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
NCT02992652 ·Status: COMPLETED ·Phase: NA
-
Enteral Nutrition Product in Mild Acute Pancreatitis
NCT01249963 ·Status: UNKNOWN ·Phase: NA
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals
NCT06610695 ·Status: ENROLLING_BY_INVITATION
-
Inmediate Feeding Tolerance in Acute Pancreatitis
NCT03354065 ·Status: COMPLETED ·Phase: NA
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)
NCT03477903 ·Status: TERMINATED ·Phase: PHASE2
-
The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 2)
NCT07303868 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
NCT01466894 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intervention to Reduce Body Burdens of PCBs in Residents of Anniston, Alabama
NCT01261338 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The HOME Study (HPN With OMEGA-3)
NCT03282955 ·Status: COMPLETED ·Phase: PHASE4
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Phase III ALTU-135 CP Safety Trial
NCT00500084 ·Status: TERMINATED ·Phase: PHASE3